ARTICLE | Regulation
Risk management plan
March 13, 2006 8:00 AM UTC
Biogen Idec's proposed risk management plan aims to ensure that patients cannot receive Tysabri unless they are informed of the risks, and to minimize the possibility that patients who contract progre...